Contents
Issue 111 • October 2021
In association with
In association with
In Depth
Unpacking the challenge of biologics
Living medicine: the bacteria fighting breast cancer
The marred history of HIV vaccine trials
Has Covid-19 exposed weakenesses in the US pharma supply chain?
Pushing pharmacovigilance to innovate post-pandemic
ExeVir: the llama-derived antibody that could fight Covid-19
Comment
Global scope for China and biotech